Natus Sensory Acquires TheraB Medical
February 11, 2026
Natus Sensory has acquired TheraB Medical, a developer of the SnugLit wearable phototherapy swaddle for neonatal jaundice, following the product's FDA 510(k) clearance in January 2026. The acquisition expands Natus Sensory's newborn care portfolio by adding a portable, family-centered phototherapy option intended to broaden treatment settings and global access.
- Buyers
- Natus Sensory
- Targets
- TheraB Medical
- Industry
- Medical Devices
- Location
- Michigan, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Natus Sensory Acquires Keriton to Expand Newborn Care Platform
January 28, 2026
Cloud & SaaS
Natus Sensory has acquired Keriton, a U.S.-based provider of cloud-based neonatal and pediatric feeding management software. The acquisition integrates Keriton's feeding safety and workflow platform into Natus Sensory's newborn care portfolio to expand connected care capabilities and accelerate adoption across hospitals and NICUs worldwide.
-
Medtronic Acquires SonarMed
May 10, 2021
Medical Devices
Medtronic plc acquired SonarMed, a Purdue‑bred developer of the SonarMed airway monitoring system, in December 2020. The acquisition adds continuous acoustic airway monitoring technology for neonatal and pediatric ventilation to Medtronic's respiratory/medical surgical portfolio to help detect endotracheal tube obstruction and position in real time.
-
ArchiMed Acquires Natus Medical Incorporated
July 21, 2022
Medical Devices
ArchiMed, through its MED Platform II fund, completed a take‑private acquisition of Natus Medical Incorporated, with Natus shareholders receiving $33.50 per share. ArchiMed said it will internationalize and grow Natus' neurodiagnostics product portfolio, reinforce R&D, and pursue complementary bolt‑on acquisitions.
-
MoodSpark (Telememory Holding Corp) Acquires Dthera Sciences
May 11, 2022
Medical Devices
Telememory Holding Corp (dba MoodSpark) has acquired Dthera Sciences, a San Diego–based pioneer in digital therapeutics, bringing Dthera’s FDA Breakthrough-designated device, patents, and clinical pilot research under the MoodSpark platform. The deal expands MoodSpark’s intellectual property and clinical capabilities in digital reminiscence therapy and cognitive behavioral interventions for seniors with Alzheimer’s and dementia, accelerating its offering for senior and veteran populations.
-
NeoLight Acquires Phoenix Technology Group
November 17, 2021
Medical Devices
NeoLight LLC, an Arizona State University spinout and Scottsdale-based newborn medical device company, has acquired Phoenix Technology Group LLC (PTG), a provider of ophthalmic imaging devices and a telemedicine platform for retinopathy of prematurity (ROP) screening. The deal expands NeoLight’s product portfolio to include the Phoenix ICON camera systems and the Phoenix CONNECT telemedicine platform and aims to leverage PTG’s global distribution to accelerate adoption of NeoLight’s Skylife neonatal phototherapy products.
-
CVC Acquires Therakos Business from Mallinckrodt for $925M
August 5, 2024
Medical Devices
CVC Capital Partners Fund IX agreed to acquire the Therakos extracorporeal photopheresis business from Mallinckrodt plc for $925 million in a carve-out transaction. CVC said it will invest in further research, indication expansion and geographic growth of Therakos while key Therakos employees will transition with the business; Mallinckrodt will use proceeds to substantially reduce net debt.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.